SCHEMBL19494899

SCHEMBL19494899

Cc1c(SN2CCOCC2)sc(NC(=O)C(C)(C)C)c1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ ANO1 Q5XXA6 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ CNR2 P34972 3/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ ABCC1 P33527 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16263777 0.76 CNR2 (0.51) ALDH1A1MAPTKMT2AMEN1HTT
SCHEMBL19494602 0.69 JAK2 (0.34) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL5467520 0.65 ANO1 (0.67) ALDH1A1KMT2AMEN1HTTANO1
SCHEMBL16337834 0.65 CFTR (0.54) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL19494391 0.63 IKBKB (0.34) ALDH1A1MAPTKMT2AMEN1HPGD
SCHEMBL18044873 0.62 ALDH1A1 (0.40) ALDH1A1MAPTKMT2AMEN1HTT
SCHEMBL8289832 0.61 ANO1 (0.92) ALDH1A1MAPTKMT2AMEN1ANO1
SCHEMBL3924390 0.61 ANO1 (0.97) ALDH1A1MAPTKMT2AMEN1ANO1
SCHEMBL8289690 0.60 ANO1 (1.00) ALDH1A1MAPTKMT2AMEN1ANO1
SCHEMBL18902108 0.59 ALDH1A1 (0.40) ALDH1A1MAPTKMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback